Kiniksa Pharmaceuticals International, plc (KNSA)
NASDAQ: KNSA · Real-Time Price · USD
41.67
+0.68 (1.66%)
At close: Dec 5, 2025, 4:00 PM EST
42.00
+0.33 (0.79%)
After-hours: Dec 5, 2025, 4:43 PM EST
KNSA Stock Forecast
Stock Price Forecast
The 6 analysts with 12-month price forecasts for KNSA stock have an average target of 51.33, with a low estimate of 44 and a high estimate of 60. The average target predicts an increase of 23.18% from the current stock price of 41.67.
Analyst Consensus: Strong Buy
* Price targets were last updated on Oct 29, 2025.
Analyst Ratings
The average analyst rating for KNSA stock from 6 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 | Dec '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 3 | 4 | 4 | 4 |
| Buy | 4 | 4 | 4 | 4 | 4 | 2 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 6 | 7 | 8 | 8 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Goldman Sachs | Goldman Sachs | Strong Buy Maintains $45 → $55 | Strong Buy | Maintains | $45 → $55 | +31.99% | Oct 29, 2025 |
| Citigroup | Citigroup | Strong Buy Maintains $45 → $50 | Strong Buy | Maintains | $45 → $50 | +19.99% | Oct 17, 2025 |
| Wedbush | Wedbush | Buy Maintains $38 → $44 | Buy | Maintains | $38 → $44 | +5.59% | Oct 13, 2025 |
| TD Cowen | TD Cowen | Strong Buy Initiates $60 | Strong Buy | Initiates | $60 | +43.99% | Sep 29, 2025 |
| Wells Fargo | Wells Fargo | Buy Maintains $42 → $45 | Buy | Maintains | $42 → $45 | +7.99% | Sep 25, 2025 |
Financial Forecast
Revenue This Year
688.32M
from 423.24M
Increased by 62.63%
Revenue Next Year
894.30M
from 688.32M
Increased by 29.93%
EPS This Year
1.00
from -0.60
EPS Next Year
1.72
from 1.00
Increased by 72.42%
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 710.2M | 990.2M | ||||
| Avg | 688.3M | 894.3M | ||||
| Low | 659.4M | 795.9M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 67.8% | 43.9% | ||||
| Avg | 62.6% | 29.9% | ||||
| Low | 55.8% | 15.6% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 1.22 | 2.55 | ||||
| Avg | 1.00 | 1.72 | ||||
| Low | 0.86 | 1.20 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | - | 155.5% | ||||
| Avg | - | 72.4% | ||||
| Low | - | 19.8% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.